DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Graphene Particles Interfere with Pro-Inflammatory Polarization of Human Macrophages: Functional and Electrophysiological Evidence
© 2021 The Authors, The interaction of two types of fragmented graphene particles (30–160 nm) with human macrophages is studied. Since macrophages have significant phagocytic activity, the incorporation of graphene particles into cells has an effect on the response to functional polarization stimuli, favoring an anti-inflammatory profile. Incubation of macrophages with graphene foam particles, prepared by chemical vapor deposition, and commercially available graphene nanoplatelet particles does not affect cell viability when added at concentrations up to 100 µg mL−1; macrophages exhibit differential quantitative responses to each type of graphene particles. Although both materials elicit similar increases in the release of reactive oxygen species, the impact on the transcriptional regulation associated with the polarization profile is different; graphene nanoplatelets significantly modify this transcriptomic profile. Moreover, these graphene particles differentially affect the motility and phagocytosis of macrophages. After the incorporation of both graphene types into the macrophages, they exhibit specific responses in terms of the mitochondrial oxygen consumption and electrophysiological potassium currents at the cell plasma membrane. These data support the view that the physical structure of the graphene particles has an impact on human macrophage responses, paving the way for the development of new mechanisms to modulate the activity of the immune system., This work was supported by grants SAF2017-82436R, PID2019-104366RB-C21, RyC-2015-18968, and PID2020-113238RB-I00 from MINECO/AEI/FEDER/EU; S2017/BMD-3686 and NMAT2D-CM P2018/ NMT-4511 from Comunidad de Madrid; CIVP18A3864 from Fundación Ramón Areces; Ayuda para la incorporación y retención de talento doctor, Programa Propio de I+D+i 2019 and 2020 from UPM and CIBERCV and CIBERHED (funded by the Instituto de Salud Carlos III) and Fondos FEDER.
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 SAF2017-82436-R
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2019-104366RB-C21
,
MINECO / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RYC-2015-18968
,
AEI PID2020-113238RB-I00